AU5924396A - Compositions and methods for the diagnosis of, and vaccinati on against, hepatitis c virus (hcv) - Google Patents

Compositions and methods for the diagnosis of, and vaccinati on against, hepatitis c virus (hcv)

Info

Publication number
AU5924396A
AU5924396A AU59243/96A AU5924396A AU5924396A AU 5924396 A AU5924396 A AU 5924396A AU 59243/96 A AU59243/96 A AU 59243/96A AU 5924396 A AU5924396 A AU 5924396A AU 5924396 A AU5924396 A AU 5924396A
Authority
AU
Australia
Prior art keywords
vaccinati
hcv
hepatitis
virus
diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU59243/96A
Inventor
Jaw-Ching Liao
Cheng-Nan Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BioNova Corp
Original Assignee
BioNova Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BioNova Corp filed Critical BioNova Corp
Publication of AU5924396A publication Critical patent/AU5924396A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109—Hepatitis C virus; Hepatitis G virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU59243/96A 1995-05-22 1996-05-22 Compositions and methods for the diagnosis of, and vaccinati on against, hepatitis c virus (hcv) Abandoned AU5924396A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44727695A 1995-05-22 1995-05-22
US447276 1995-05-22
PCT/US1996/007378 WO1996037606A1 (en) 1995-05-22 1996-05-22 Compositions and methods for the diagnosis of, and vaccination against, hepatitis c virus (hcv)

Publications (1)

Publication Number Publication Date
AU5924396A true AU5924396A (en) 1996-12-11

Family

ID=23775707

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59243/96A Abandoned AU5924396A (en) 1995-05-22 1996-05-22 Compositions and methods for the diagnosis of, and vaccinati on against, hepatitis c virus (hcv)

Country Status (3)

Country Link
AU (1) AU5924396A (en)
IL (1) IL118364A0 (en)
WO (1) WO1996037606A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101126095A (en) * 1998-01-30 2008-02-20 总医院有限公司 Genetic immunization with nonstructural proteins of hepatitis c virus
US7078500B1 (en) 1998-01-30 2006-07-18 The General Hospital Corporation Genetic immunization with nonstructural proteins of hepatitis C virus
GB0226722D0 (en) * 2002-11-15 2002-12-24 Glaxo Group Ltd Vaccine
BR102018071672A2 (en) * 2018-10-22 2021-11-16 Fundação Oswaldo Cruz POLYPEPTIDE, EXPRESSION CASSETTE, EXPRESSION VECTOR, HOST CELL, KIT FOR IMMUNOLOGICAL SCREENING OF HCV AND/OR DIAGNOSIS OF HEPATITIS C, COMPOSITION, USE OF AT LEAST ONE POLYPEPTIDE, AND, METHODS FOR PRODUCING A HCV, PARAPEPTIDE FOR THE DIAGNOSIS OF HEPATITIS C

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR940000755B1 (en) * 1990-02-16 1994-01-29 유나이티드 바이오메디칼 인코오포레이티드 Synthetic peptides specific for the detection of antibodies to hcv
KR100206150B1 (en) * 1990-04-04 1999-07-01 로버트 피. 블랙버언 Combinations of hepatitis c virus(hcv)antigens for use in immunoassays for anti-hcv antibodies
AU652941B2 (en) * 1990-06-25 1994-09-15 Research Foundation For Microbial Diseases Of Osaka University, The Non-A, Non-B hepatitis virus particles
GB9203803D0 (en) * 1992-02-21 1992-04-08 Wellcome Found A recombinant polypeptide
KR100312535B1 (en) * 1993-04-30 2002-06-20 성재갑 Diagnostic kit of antibody to hepatitis c virus(hcv) using mixed antigen

Also Published As

Publication number Publication date
IL118364A0 (en) 1996-09-12
WO1996037606A1 (en) 1996-11-28

Similar Documents

Publication Publication Date Title
AU2550995A (en) Hepatitis c virus asialoglycoproteins
AU6304996A (en) Vaccines against hepatitis c
AU5285899A (en) Anti hepatitis c virus antibody and uses thereof
AU3495395A (en) Cyclic cs-1 peptidomimetics, compositions and methods of using the same
EP0745128B8 (en) Hepatitis b virus mutants, reagents and methods for detection
IL131688A0 (en) Functional dna clone for hepatitis c virus (hcv) and uses thereof
CA2110058A1 (en) Hepatitis c virus (hcv) polypeptides
AU1566595A (en) Method and reagent for inhibiting hepatitis c virus replication
EP0759072A4 (en) Poxvirus-canine distemper virus (cdv) recombinants and compositions and methods employing the recombinants
AU6093296A (en) Infectious dengue 2 virus pdk-53 as quadravalent vaccine
AU652941B2 (en) Non-A, Non-B hepatitis virus particles
AU1224100A (en) Reference clones and sequences for non-subtype b isolates of human immunodeficiency virus type 1
EP0593290A3 (en) Core antigen protein of hepatitis C virus, and diagnostic method and kit using the same.
AU7262198A (en) Methods and reagents for rapid diagnosis of dengue virus infection
AU1905399A (en) Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds
AU5729296A (en) Soluble, cleavable substrates of the hepatitis c virus prote ase
AU5289193A (en) New influenza virus peptides, diagnostics and vaccines
AU4193789A (en) Detection of non-a, non-b hepatitis
AU3467697A (en) 3'-oximino-2',3'-dideoxynucleosides and derivatives of the same
AU5924396A (en) Compositions and methods for the diagnosis of, and vaccinati on against, hepatitis c virus (hcv)
ZA964094B (en) Compositions and methods for the diagnosis of and vaccination against hepatitis c virus (hcv)
AU4132096A (en) Compositions and methods for interfering with hepatitis b virus infection
AU6157996A (en) Nucleotide and amino acid sequences of hypervariable region 1 of the envelope 2 gene of hepatitis c virus
AU696608B2 (en) Method for diagnosing chronic hepatitis B virus infection
AU6221996A (en) Oligonucleotides specific for hepatitis c virus